Chronic News and Research

RSS

Researchers develop "smart" hydrogel that can deliver medicine on demand

Researchers at the University of Delaware have developed a "smart" hydrogel that can deliver medicine on demand, in response to mechanical force.

16 Jan 2014

Bill seeks team-based approach to caring for Medicare patients with chronic illness

Sen. Ron Wyden plans to unveil a bill to encourage team-based care in the program for older and disabled Americans. In the meantime, Medicare readies to deliver payment data for individual doctors on a "case-by-case" basis.

16 Jan 2014

New way to improve lipid profiles in patients undergoing hemodialysis may prevent heart attack

Researchers at Wayne State University have discovered a potential way to improve the lipid profiles in patients undergoing hemodialysis that may prevent cardiovascular disease common in these patients.

16 Jan 2014

New drug combination proves effective in treatment of hepatitis C

Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere.

16 Jan 2014

Spinal cord injury patients could benefit from careful assessment for sleep apnea

A new study suggests that patients with spinal cord injuries could benefit from careful assessment for sleep apnea.

15 Jan 2014

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

A Montr-al research team led by Jennifer Estall at the IRCM discovered that a protein found in muscle tissue may contribute to the development of type 2 diabetes later in life. The study's results, published in today's printed edition of the scientific journal American Journal of Physiology - Endocrinology and Metabolism, indicate that the protein could be a promising early predictor of increased diabetes risk.

15 Jan 2014

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.

15 Jan 2014

Latham & Watkins recognized with CEO Cancer Gold Standard accreditation

Latham & Watkins, a leading global law firm, is working with its lawyers and staff to promote healthy lifestyle choices and encourage workplace wellness. The CEO Roundtable on CancerTM has accredited Latham & Watkins with the CEO Cancer Gold Standard recognizing the firm's efforts to reduce the risk of cancer for its employees and covered family members by establishing programs to reduce cancer risk, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

15 Jan 2014

New gold nanoparticle method allows for tracking studies of virus pathways in tissues

Enteroviruses are pathogenic viruses infecting humans. This group consists of polioviruses, coxsackieviruses, echoviruses and rhinoviruses. Enteroviruses are the most common causes of flu, but they also cause serious symptoms such as heart muscle infections and paralysis. Recently, enteroviruses have been linked with chronic diseases such as diabetes.

15 Jan 2014

Joslin Diabetes Center launches pilot program with Truman Medical Centers to test JCAT

Joslin Diabetes Center, an affiliate of Harvard Medical School, has launched a pilot program in conjunction with Truman Medical Centers, the primary teaching hospital for the University of Missouri-Kansas City Schools of Medicine to test the capabilities of a novel and innovative care analytics tool called the Joslin Clinical Analytical Tool (JCAT™).

15 Jan 2014

Idiopathic pulmonary fibrosis (IPF) and herpesvirus saimiri: an interview with Elazar Rabbani, Chief Executive Officer of Enzo

Pulmonary fibrosis is a condition where fibrotic or scarred tissue progressively develops in the lungs. In some cases the particular cause is known but in others it remains unknown and is given the term “idiopathic”.

14 Jan 2014

First Edition: January 13, 2014

Today's headlines include news about how the health law's enrollment process is working and about the federal government's decision not to renew the contract for the company that was overseeing the repairs for healthcare.gov.

13 Jan 2014

Smoking and cancer: an interview with Dr. Lewis Foxhall, VP of Health Policy, University of Texas MD Anderson Cancer Center

The report Smoking and Health: Report of the Advisory Committee to the Surgeon General, identified tobacco as the predominant cause of lung cancer in men. This was the first widely disseminated report based on scientific studies showing the clear link between smoking tobacco and serious health conditions including cancer, chronic lung diseases and heart disease.

13 Jan 2014

Radius Medical launches new PRODIGY Support Catheter in the U.S.

Radius Medical, LLC. today announced the FDA clearance and product launch of its new PRODIGY™ Support Catheter. Engineered to provide back up support to the guidewire when encountering difficult to cross lesions, the PRODIGY Support catheter will be a critical component in the revolutionary techniques now being developed in treating chronic total occlusions.

10 Jan 2014

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema - a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.

10 Jan 2014

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.

9 Jan 2014

Chronic News and Research

Researchers develop "smart" hydrogel that can deliver medicine on demand

Bill seeks team-based approach to caring for Medicare patients with chronic illness

New way to improve lipid profiles in patients undergoing hemodialysis may prevent heart attack

New drug combination proves effective in treatment of hepatitis C

Spinal cord injury patients could benefit from careful assessment for sleep apnea

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Latham & Watkins recognized with CEO Cancer Gold Standard accreditation

New gold nanoparticle method allows for tracking studies of virus pathways in tissues

Joslin Diabetes Center launches pilot program with Truman Medical Centers to test JCAT

Idiopathic pulmonary fibrosis (IPF) and herpesvirus saimiri: an interview with Elazar Rabbani, Chief Executive Officer of Enzo

First Edition: January 13, 2014

Smoking and cancer: an interview with Dr. Lewis Foxhall, VP of Health Policy, University of Texas MD Anderson Cancer Center

Radius Medical launches new PRODIGY Support Catheter in the U.S.

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

IQWiG publishes new clinical practice guidelines for treating people with COPD

Democrats reject GOP offer: Jobless benefits for health law suspension

Study finds discrepancies in prevalence estimates of mental disorders in middle-aged and older adults

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News